Approvals/TGA/VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack

Approved

STANDARD

VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c28d8c1121d2e34e
Product Name: VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack
Artg Id: 316241
Artg Name: VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2020-03-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

c28d8c1121d2e34e

Type

Standard